Actively Recruiting

Phase Not Applicable
Age: 0Years - 80Years
All Genders
Healthy Volunteers
NCT06835738

Implementation of Multiple Micronutrient Supplementation (MMS) for Pregnant Women in Uganda

Led by Johns Hopkins Bloomberg School of Public Health · Updated on 2025-07-03

4077

Participants Needed

1

Research Sites

80 weeks

Total Duration

On this page

Sponsors

J

Johns Hopkins Bloomberg School of Public Health

Lead Sponsor

V

Vitamin Angels

Collaborating Sponsor

AI-Summary

What this Trial Is About

The objective of this research is to understand how antenatal multiple micronutrient supplements (MMS) can be effectively implemented and scaled within the Uganda national health system context to support improved maternal nutrition and birth outcomes. Formative research has been conducted to design the implementation strategies that will be tested in this second phase of the study. The objectives are to: * Describe the implementation of the MMS intervention (which consists of MMS product, a social behavior change communication (SBCC) strategy, capacity building, MMS supply chain support, monitoring, and evaluation) and explore acceptability, feasibility, fidelity, coverage, and potential for sustainability. * Determine the effect of dispensing MMS in different bottle counts on MMS adherence and ANC attendance among pregnant women. * Determine the cost and budget impact of MMS intervention implementation integrated in the Ugandan ANC service delivery system

CONDITIONS

Official Title

Implementation of Multiple Micronutrient Supplementation (MMS) for Pregnant Women in Uganda

Who Can Participate

Age: 0Years - 80Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Pregnant women with 24 weeks of amenorrhea or less verified by health professionals
  • Attending first antenatal care visit at government or private-not-for-profit health facilities
  • Accepted to take multiple micronutrient supplements at first antenatal care visit
  • Currently pregnant or no more than 8 weeks postpartum
  • Received MMS at an antenatal care visit at least 3 months ago or more
  • Attended at least two monthly antenatal care visits
  • Attending or attended antenatal care at government or private-not-for-profit health facilities
  • Healthcare providers currently providing antenatal care health education or counseling at government or private-not-for-profit facilities
  • Spouse or partner of a pregnant woman or woman with a child less than 8 weeks old receiving or having received antenatal care services in one of the study districts
  • Mother or mother-in-law of a pregnant woman or woman with a child less than 8 weeks old receiving or having received antenatal care services in one of the study districts
  • Health workers providing antenatal care services at government or private-not-for-profit facilities in study districts
  • Health facility staff such as facility in-charge, maternity in-charge, pharmacy/stores in-charge at government or private-not-for-profit facilities in study districts
  • Voluntary Health Team members, Mentor Mothers, or Para-socials attached to at least one study facility
  • National, regional, or district-level decision-makers working in nutrition, maternal, newborn, and child health or related roles associated with antenatal care in Uganda
  • Implementing partners involved in direct implementation of MMS within the study districts
  • Women who have been pregnant or delivered within the study period and live in one of the selected districts
Not Eligible

You will not qualify if you...

  • Pregnant women with pre-existing hematological conditions such as sickle cell anemia, thalassemia, or hemochromatosis
  • Pregnant women planning to relocate outside the study district during the study period
  • Women enrolled in the pregnancy follow-up group (sample 1) if in the single contact group (sample 2)
  • Women more than 8 weeks postpartum
  • Healthcare providers who have not provided written informed consent to have antenatal care sessions observed
  • Women who moved to the district after delivery during the household coverage survey

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Lyantonde GH

Lyantonde, Uganda

Actively Recruiting

Loading map...

Research Team

H

Harriet Babikako, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here